Single-cell analysis reveals immune dysfunction from the earliest stages of CLL that can be reversed by ibrutinib.
Purroy N, Tong YE, Lemvigh CK, Cieri N, Li S, Parry EM, Zhang W, Rassenti LZ, Kipps TJ, Slager SL, Kay NE, Lesnick C, Shanafelt TD, Ghia P, Scarfò L, Livak KJ, Kharchenko PV, Neuberg DS, Olsen LR, Fan J, Gohil SH, Wu CJ.
Purroy N, et al. Among authors: shanafelt td.
Blood. 2022 Apr 7;139(14):2252-2256. doi: 10.1182/blood.2021013926.
Blood. 2022.
PMID: 35020831
Free PMC article.
No abstract available.